Literature DB >> 5686481

Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin.

L D Sabath, D A Gerstein, M Finland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5686481     DOI： 10.1056/NEJM196811212792104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Hepatotoxicity of erythromycin estolate during pregnancy.

Authors:  W M McCormack; H George; A Donner; L F Kodgis; S Alpert; E W Lowe; E H Kass
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

2.  The clinical significance of the SGOT test.

Authors:  R R Babb
Journal:  Calif Med       Date:  1973-05

3.  A comparison of the erythromycin estolate and tetracycline in the treatment of respiratory tract infections.

Authors:  S N Tewari; M M Gupta
Journal:  J R Coll Gen Pract       Date:  1970-08

Review 4.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

Review 5.  Drug interferences with clinical laboratory tests.

Authors:  P P Sher
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

Review 6.  Enzyme assays in liver disease.

Authors:  R J Wieme; L Demeulenaere
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1970

7.  In vitro induction of resistance to erythromycin by its metabolite.

Authors:  J Majer
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

Review 8.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 9.  Persistent elevation of aspartate aminotransferase in a child after incomplete Kawasaki disease: a case report and literature review.

Authors:  Pejman Rohani; Farid Imanzadeh; Aliakbar Sayyari; Maryam Kazemi Aghdam; Reza Shiari
Journal:  BMC Pediatr       Date:  2020-02-17       Impact factor: 2.125
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.